In humans, homozygous mutation in the CAV1 gene causes CGL3, where affected patients have postprandial hyperinsulinemia, severe insulin resistance, hypertriglyceridemia, and lipodystrophy [51]. Here, CAV1 is linked to Insulin resistance.